Featured series 
Tag: Amyloid beta
-
Nation & World
Start of new era for Alzheimer’s treatment
Neurologist explains why recent trial of the drug lecanemab may offer hope for those with deadly disease.
-
Nation & World
Tracking the proteins before Alzheimer’s takes hold
A team led by investigators has now developed an automated method that can identify and track the development of two key abnormal protein deposits that accumulate in the brain during the development of Alzheimer’s disease.
-
Nation & World
Probe of Alzheimer’s follows paths of infection
Starting with microbes, Harvard-MGH researchers outline a devastating chain of events
-
Nation & World
Alzheimer’s insights in single cells
A study of plaque production at single-cell level holds promise to help improve Alzheimer’s treatment.
-
Nation & World
Alzheimer’s in a dish
Harvard stem cell scientists have successfully converted skins cells from patients with early onset Alzheimer’s into the types of neurons affected by the disease, making it possible for the first time to study this leading form of dementia in living human cells.
-
Nation & World
Brain changes found in normal elders
Harvard-affiliated researchers using two brain-imaging technologies have found that apparently normal older individuals with brain deposits of amyloid beta — the primary constituent of the plaques found in the brains of Alzheimer’s disease patients — also had changes in brain structure similar to those seen in Alzheimer’s patients.
